Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Contentious grain bill put directly to plenary meeting for vote

    Contentious grain bill put directly to plenary meeting for vote
  2. 2

    Yoon's approval rating plunges to all-time low

    Yoon's approval rating plunges to all-time low
  3. 3

    Will tug-of-war between doctors, government end soon?

    Will tug-of-war between doctors, government end soon?
  4. 4

    Climate impacts set to cut 2050 global GDP by nearly a fifth

    Climate impacts set to cut 2050 global GDP by nearly a fifth
  5. 5

    Trilateral talks acknowledge ‘serious’ slumps of won, yen

    Trilateral talks acknowledge ‘serious’ slumps of won, yen
  1. 6

    [Graphic News] More Koreans say they plan long-distance trips this year

    [Graphic News] More Koreans say they plan long-distance trips this year
  2. 7

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
  3. 8

    North Korea removes streetlights along cross-border roads with South

    North Korea removes streetlights along cross-border roads with South
  4. 9

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
  5. 10

    Farming households dip below 1m for first time in 2023

    Farming households dip below 1m for first time in 2023
피터빈트

Pharmaceutical firms' exports of API increase

By KH디지털2

Published : April 18, 2017 - 11:03

    • Link copied

South Korea's major pharmaceutical firms saw their revenues from exports of Active Pharmaceutical Ingredients increase last year, industry sources said Tuesday.

API refers to key chemicals used to produce pharmaceutical drugs.

Yuhan Corp., a major drug company, said its revenue from overseas shipments of API jumped nearly 30 percent on-year to 250 billion won ($220 million) in 2016, company officials said.

(Yonhap) (Yonhap)

Yuhan said its API business also accounts for 19 percent of the company's total revenue worth 1.32 trillion won.

Major demand growth comes from leading global pharmaceutical companies such as Pfizer Inc. which manufacturers drugs for AIDS and high-priced Hepatitis C treatment.

ST Farm, a subsidiary under Dong-A Socio Holdings Co. manufacturing API, also generates 82 percent of its revenue from overseas shipments.

The company currently exports API for anti-virus to the Britain-based pharmaceutical company GlaxoSmithKline Plc. as well as Swiss pharmaceutical giant Novartis.

Chong Kun Dang Bio, an API arm of Chong Kun Dang Pharmaceutical, said 81 percent of its revenue came from overseas markets. (Yonhap)

More from Headlines